Chicago Marriott Downtown Magnificent Mile
June 1, 2008 .
Not an official event of the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting. Not sponsored or endorsed by ASCO or The ASCO Foundation.
Acknowledgement of Commercial Support
The CBCE and Sarcoma Foundation of America gratefully acknowledge the educational grant provided by: ARIAD Pharmaceuticals, Inc.; Novartis Oncology; Pfizer; PharmaMar, S.A.; Roche Pharmaceuticals; Infinity Pharmaceuticals, Inc.; Daiichi Sankyo Pharma Development; EMD Serono, Inc.; and IDM Pharma
PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
01 junio 2008
ASCO 2008 , Pharma Mar y J&J en el Scientific Program Committee Disclosure Index .
Pagina 3 J&J Y Pharma Mar en Developmental Therapeutics–Cytotoxic Chemotherapy .
Pagina 7 Pharma Mar en Genitourinary Cancer .
Pagina 8 J&J en Gynecologic Cancer .
Pagina 12 J&J en Sarcoma .
Pagina 7 Pharma Mar en Genitourinary Cancer .
Pagina 8 J&J en Gynecologic Cancer .
Pagina 12 J&J en Sarcoma .
Suscribirse a:
Entradas (Atom)